Analysis of sleep quality, disease uncertainty, and psychological tolerance in patients undergoing chemotherapy for digestive tract malignancies

Table 6 Analysis of Factors Influencing Sleep Disorders in Chemotherapy Patients with Gastrointestinal Malignant Tumors

Factors	β	SE	Wald χ2	OR	P value	95%CI
Age	0.353	0.276	1.636	1.423	0.202	0.829-2.445
Chemotherapy frequency	0.255	0.184	1.921	1.290	0.167	0.900-1.851
Pain level	0.457	0.273	2.802	1.579	0.095	0.925-2.697
SAS score	0.291	0.115	6.403	1.338	0.012	1.068-1.676
SDS score	0.284	0.118	5.793	1.328	0.017	1.054-1.674
Ward noise	0.365	0.176	4.301	1.441	0.039	1.020-2.034
MUIS-A score	0.357	0.148	5.819	1.429	0.016	1.069-1.910
CD-RISC score	-0.426	0.106	16.151	0.653	< 0.001	0.531-0.804

MUIS-A: Mishel Uncertainty in Illness Scale for Adults; CD-RISC: Connor-Davidson Resilience Scale; SAS: Self-rating anxiety scale; SDS: Self-rating depression scale.